Kisspeptin-10: A Neuroendocrine Research Signal, Not a Fertility Shortcut

Reviewed for accuracy by the Gorilla Research Insights research team · 2026-07-04

PEPTIDE RESEARCH SERIES Kisspeptin-10: A Neuroendocrine Research Signal, Not a Fertility Shortcut Kisspeptin-10 is the C-terminal decapeptide of kisspeptin with activity at KISS1R. Human experiments use it to probe the hypothalamic–pituitary–gonadal axis, especially gonadotropin-releasing-hormone signaling inferred through luteinizing hormone responses.

What controlled studies show

In a small study of healthy men, intravenous kisspeptin-10 produced rapid, dose-dependent luteinizing-hormone responses; continuous experimental infusion changed pulse characteristics ^[1]. In another controlled study, repeated kisspeptin-54 exposure in women with hypothalamic amenorrhea produced an acute gonadotropin response followed by marked tachyphylaxis ^[2]. The latter used kisspeptin-54, not kisspeptin-10, so it informs pathway behavior rather than product equivalence.

What remains uncertain

These short, closely supervised physiology studies do not establish fertility outcomes, long-term endocrine effects, broad safety, or effectiveness in the general population. Responses vary with sex-steroid environment, peptide form, route, timing, and underlying physiology. No conclusion about a research product’s identity or bioactivity follows from literature on a clinical-study preparation.

Research priorities

• Separate acute receptor activation from desensitization during repeated exposure. • Compare kisspeptin forms without assuming interchangeability. • Use prespecified endocrine and clinically meaningful endpoints in larger trials.

Primary sources

• ^[1] George JT, et al. Kisspeptin-10 stimulation of LH and pulse frequency in men. PubMed . • ^[2] Jayasena CN, et al. Acute response and tachyphylaxis during repeated kisspeptin-54 administration. PubMed . Educational research summary only; not medical advice or instructions for use.